Back

Superior vena cava isolation in paroxysmal atrial fibrillation - mind the phrenic

8 April 2024 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 3 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Vedran Pasara

University Hospital Centre Zagreb, Zagreb (Croatia)

7 More presentations in this session

Presentation thumbnail
Very-high power short duration radiofrequency ablation (90W/4seconds) under mild conscious sedation: lesion metrics and 12-month outcomes
Doctor M. Mills (Sheffield, GB)
Abstract Slides Video
Presentation thumbnail
The impact of cardiac rehabilitation on atrial fibrillation recurrence after pulmonary vein isolation: results of a retrospective study.
Miss R. Onder (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Pressure-guided evaluation of pulmonary vein occlusion during cryoballoon pulmonary vein isolation for atrial fibrillation compared to contrast-guided approach
Mr O. Alothman (Bad Berka, DE)
Abstract Slides Video
Presentation thumbnail
Low voltage area in the left atrial anterior wall predict Marshall-PLAN failure in patients with persistent atrial fibrillation.
Doctor L. Limite (Perpignan, FR)
Abstract Slides Video
Presentation thumbnail
Endoscopic versus surgical treatment for the management of oesophageal fistula after atrial fibrillation ablation - a subanalysis of the worldwide POTTER-AF study
Doctor S. Popescu (Luebeck, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 3 - ablation

The Event

Event poster

EHRA 2024

8 April 2024 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Superior vena cava isolation in addition to standard pulmonary vein isolation by fourth-generation cryoballoon for paroxysmal atrial fibrillation - mid-term outcomes of a randomized trial
thumbnail
Congress Presentation
Empirical superior vena cava cryoballoon ablation fails to improve freedom from atrial fibrillation in paroxysmal atrial fibrillation: 2-year outcomes of a randomized trial
thumbnail
Congress Presentation
Superior vena cava is associated with improved outcomes in atrial fibrillation ablation, as part of a patient- tailored approach: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources